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C-Terminally modiﬁed peptides via cleavage of
the HMBA linker by O-, N- or S-nucleophiles†
J. Hansen, F. Diness and M. Meldal*
A large variety of C-terminally modiﬁed peptides was obtained by nucleophilic cleavage of the ester bond
in solid phase linked peptide esters of 4-hydroxymethyl benzamide (HMBA). The developed methods
provided peptides, C-terminally functionalized as esters, amides and thioesters, with high purity directly
from the resin in a single reaction step. A comprehensive screening of the reaction conditions and scope
for nucleophilic cleavage of peptides from the HMBA linker was performed.
Introduction
The ever expanding applications of solid phase peptide syn-
thesis (SPPS)1 for the preparation of bioactive peptides and
small proteins have been a driving force in the development of
numerous linkers for C-terminal attachment of peptides to
polymer resins.2,3 However, most linkers are only eﬀectively
cleaved under one set of cleavage conditions and they produce
only a single functionality in the cleavage step. Hence, when
several C-terminal derivatives of a particular peptide are
required, a diﬀerent linker is needed for each derivative. This
is in contrast to modification of the N-terminus of peptides,
which may be freely functionalized while these are still
attached to the resin. C-Terminally modified peptides are
nevertheless interesting for a variety of reasons. The nature of
the C-terminal is important in medicinal chemistry, as it
impacts peptide binding, aﬀects stability and provides selecti-
vity in binding to enzymes.4,5 Of particular interest is access to
C-terminal peptide carboxylic acids, esters, thioesters and
amides, as these are found in natural peptides, in their ana-
logues or may even be needed as precursors for protein
synthesis.6–9 The majority of synthesized peptides are attached
to the solid support, either through amide or ester linkers.
Amide linkers are almost exclusively cleaved by an acid whereas
ester linkers can be cleaved by either a base or an acid, depend-
ing on the nature of the linker. Because acid labile ester linkers
are cleaved via a SN1 reaction to release the linker as a carbo-
nium ion, the cleavage occurs between the acidic oxygen and
linker carbon. Commonly, base labile ester linkers cleave via a
nucleophilic substitution reaction by attack on the carbonyl
group of the ester, which leads to cleavage between the oxygen
and the carbonyl group (Scheme 1). Hence, the applied nucleo-
phile is attached to the peptide carbonyl group after the
release and thereby provides the opportunity for modifying the
C-terminal with various nucleophiles in the cleavage step.
A commonly used base labile linker is 4-hydroxymethyl
benzamide (HMBA).10 One major benefit of the HMBA-linker
is that peptides can be deprotected with TFA, while remaining
attached to the resin. This then allows the deprotected
peptides to be screened for activity on the resin and the hit
compounds can later be cleaved for analysis, using a low con-
centration of an aqueous base. The purity of the cleaved pep-
tides is usually very high and purification is frequently not
required prior to characterization and use.11 Other base labile
linkers have been developed over the years for specialized
purposes.12–15 Concerning the functionalization of peptides,
only a few examples of cleaving the HMBA linker with other
nucleophiles than hydroxide have been reported, including
the use of ammonia/THF vapor16,17 and a study using a few
nucleophiles to produce esters and amides.18 However, a
thorough investigation on the scope of the HMBA linker, in
cleavage reactions using a variety of diﬀerent nucleophiles, has
not been performed.
Scheme 1 The diﬀerent modes of reaction observed for acid labile vs.
base labile linkers.
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Results and discussion
In order to evaluate the reaction of HMBA–esters with nucleo-
philes, three resin-bound dipeptide substrates were prepared,
in which the ester linked amino acid was varied: Ac-Trp-Gly-
HMBA-PEGA800 (1a), Ac-Trp-Ala-HMBA-PEGA800 (2a) and Ac-
Trp-Ile-HMBA-PEGA800 (3a). These substrates allowed the steric
influence at Cα on nucleophilic ester cleavage to be deter-
mined. The cleavage products were synthesized in sub-milli-
gram amounts and identified by HPLC and MS. As HMBA
linked esters are rapidly cleaved by hydroxide, it was hypo-
thesized that alkoxides would only cleave by transesterification
under strictly water free reaction conditions. Initial tests with
1,8-diazabicycloundec-7-ene (DBU) as the catalytic base in
combination with methanol or ethanol led to partial release of
the peptides as the corresponding esters. Further screening of
non-nucleophilic bases proved that potassium tert-butoxide
was superior, as it was suﬃciently strong to facilitate the
formation of the alkoxide and thereby, the reaction between all
the substrates and the investigated alcohols. Using these
conditions, four diﬀerent alcohols were reacted with three
diﬀerent resin-bound peptides (Table 1). It was found that
primary alkoxides readily eﬀect transesterification reactions of
the peptide–linker ester bond, as seen by short reaction times
and complete conversion with methanol and ethanol respecti-
vely (Table 1, entries 1–6). However, under prolonged reaction
times, the irreversible hydrolysis of the products was also fre-
quently observed. As expected the reaction time needed for full
conversion was longer for the more sterically hindered amino
acid derivatives and the more substituted alcohol nucleo-
philes. When the combination of the nucleophile and
substrate became sterically unfavorable for the reaction, con-
version proceeded more slowly and prevention of the compet-
ing hydrolysis, presumably by trace amounts of water in the
resin, proved diﬃcult.
A balanced reaction time was determined where the
product was obtained in high yield with negligible or little
hydrolysis. For instance, reactions of 10 and 13 (Table 1,
entries 7 and 10), with sterically hindered alcohols required
30 min for complete conversion. However, this period of time
resulted in approximately 80% hydrolysis, while stopping the
reactions at 15 min ensured purity of the product above 90%
with about 30% conversion. A unique eﬀect was observed for
the isoleucine substrate, as it appeared to be more resistant to
hydrolysis of the product ester.
Few other methods for obtaining peptides with C-terminal
esters from resin bound amino acids have been reported. One
method relies on a one pot two-step procedure from the Wang
linker, forming esters under acidic condensation conditions.19
Another technique utilizes preformed C-terminal esters com-
bined with acid labile linking to the resin through the side-
chains, e.g. through the thiol of cysteine.20 However, the
method presented here allows variation of the alcohol/alkoxide
in the ester formation combined with cleavage in a one-step
fashion.
In order to quantify the reactivity of the HMBA linked esters
compared to simple alkyl esters, the transesterification reac-
tions were studied in the solution phase (Scheme 2). To deter-
mine the reaction rates, the dipeptide Ac-Trp-Ala was prepared
as either 4-carbamoylbenzyl ester (16) or isobutyl ester (17).
The two esters were then used for transesterification with
ethoxide, generated by addition of potassium tert-butoxide to
ethanol. Both compounds 16 and 17 formed exclusively the
ethyl ester product (8), but at significantly diﬀerent rates. The
halftime t1/2 for the transesterification reaction was 12 seconds
for 16 and 2.25 minutes for 17, respectively. The more than
10-fold increase in the rate of transesterification of the HMBA
ester demonstrates that the application of the HMBA is
Scheme 2 Comparison of transesteriﬁcation kinetics for an aliphatic
ester and the HMBA linker.
Table 1 Release of peptides from HMBA with alcoholates as
nucleophiles
Entry R1
R2OH
(product)
Time
(min)
Conversion
(%)
Purity
(%)
1 H MeOH (4) 15 100 >95
2 Me MeOH (5) 30 100 >95
3 (S)sBu MeOH (6) 60 100 >95
4 H EtOH (7) 15 100 >95
5 Me EtOH (8) 30 100 >95
6 (S)sBu EtOH (9) 60 100 >95
7 H iPrOH (10) 15 30 >90
8 Me iPrOH (11) 30 20 >90
9 (S)sBu iPrOH (12) 120 100 >90
10 H iBuOH (13) 15 40 >90
11 Me iBuOH (14) 30 20 >90
12 (S)sBu iBuOH (15) 120 100 >90
Resin (5 mg, 1 µmol) was treated with alcohol/alcoholate (200 µL,
89 µmol). Reactions were quenched (200 µL, 1% TFA/ACN). The
solution and subsequent washings (H2O/CH3CN, 7 : 1) were analyzed
by HPLC.
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superior to alkyl esters as a leaving group in nucleophilic sub-
stitution reactions.
Aminolysis of simple alkyl esters is typically a slow process
that often requires heating. However, in light of the described
reactivity studies, aminolysis of the HMBA linked esters
seemed feasible. A series of amines were applied in reactions
with the resin bound peptide esters to produce the corres-
ponding amides. Initially sodium amide in dioxane was tested
as a nucleophile, which however resulted in complex mixtures
of products. Therefore, all reactions with amines were per-
formed with the neat primary amine, without application of
an additional base (Table 2). The diﬀerences in reaction times
and optimal conversion conditions were more pronounced
with the amines, compared to those of the alcohols. Heating
to 40 °C was attempted to increase the rate of the reactions
and to reach complete conversion. A higher degree of conver-
sion was observed, but heating also resulted in undesirable
formation of byproducts. Most amines studied, proved to be
suﬃciently nucleophilic for amides to be produced. Particu-
larly when using the glycine ester substrate, amides were
readily formed (Table 2, entries 1 and 7).
On the other hand, isoleucine proved to be too sterically
hindered to facilitate complete conversion in less than 6 hours
and only unbranched amines were suﬃciently reactive towards
the isoleucine substrate to yield peptide amides. It is note-
worthy that ethylene diamine and ethanolamine react much
faster with the isoleucine resin probably through anchimeric
assistance by the distal amine or hydroxyl group, respectively
(Table 2, entries 12 and 15). Furthermore, even though amines
are basic, no issues with hydrolysis were observed indicating
that no competing hydroxide was formed.
Reports on synthesis of N-alkyl amides of peptides are quite
scarce. However, primary amides have previously been
reported, synthesized from esters using ammonia vapor.16
A few alkyl amides have been synthesized in 13–16% yield
using the HMBA linker.18 A more elaborated alternative, has
been N-alkylation of the PAL linker with alkyl halides followed
by acid cleavage.4 The synthesis requires three steps and
several reagents, while in the present approach, the amine is
the sole reagent in a one-step reaction.
Due to the general interest in peptide thioesters for chemi-
cal ligation, 1-propanethiol was investigated as a nucleophile
in reactions with the three model substrates, 1a–3a. In this
study, an approach similar to that used for alkoxides, was
employed. Under optimized conditions, the corresponding
thioester products were obtained in high purity from peptides
1a and 2a (Table 3, entries 1 and 2). Only a limited amount
of hydrolysis was observed, presumably because deprotonated
thiols do not generate significant amounts of hydroxide in
contact with traces of water.
It was observed that in the presence of traces of oxygen, the
thiols formed disulfides under base catalysis by potassium
tert-butoxide. The problem was however significantly reduced
by passing nitrogen through the solution, during these
reactions.
Originally thioesters were reported to be synthesized using
Boc/Bzl chemistry.21,22 The progress in the synthesis of this
class of molecules has recently been reviewed, including
diﬀerent methods compatible with Fmoc-SPPS.23 A popular
method is application of the sulfonamide “safety catch” linker,
which after activation can be converted to thioesters by nucleo-
philic cleavage.24 The BAL linker may also be used to produce
thioesters but only from peptides starting with a C-terminal
glycine.25 The rearrangements O→S26 and N→S have also been
explored in linker strategies,27 where a thiol functionalized
Table 2 Release of peptides from HMBAwith amines as nucleophiles
Entry R1 R2NH2
Time
(h)
Conversion
(%)
Purity
(%)
1 H PrNH2 (19) 2 100 >95
2 Me PrNH2 (20) 4 99 >95
3 (S)sBu PrNH2 (21) 6 5 —
4 H iPrNH2 (22) 2 40 >95
5 Me iPrNH2 (23) 4 5 —
6 (S)sBu iPrNH2 (24) 6 0 —
7 H iBuNH2 (25) 2 100 >95
8 Me iBuNH2 (26) 4 60 >95
9 (S)sBu iBuNH2 (27) 6 0 —
10 H (CH2NH2)2 (28) 2 100 >90
11 Me (CH2NH2)2 (29) 4 100 >90
12 (S)sBu (CH2NH2)2 (30) 6 60 >90
13 H HO(CH2)2NH2 (31) 2 100 >90
14 Me HO(CH2)2NH2 (32) 4 100 >90
15 (S)sBu HO(CH2)2NH2 (33) 8 50 >90
Resin (5 mg, 1 µmol) was treated with amine (200 µL, neat). The
solution was drained and the resin was washed with (H2O/CH3CN/TFA,
7 : 1 : 0.1) for HPLC analysis.
Table 3 Release of peptides from HMBAwith thiolates as nucleophiles
Entry R1 R2SH
Time
(h)
Conversion
(%)
Purity
(%)
1 H PrSH (34) 6 70 60
2 Me PrSH (35) 6 70 60
3 (S)sBu PrSH (36) 6 0 —
Resin (5 mg, 1 µmol) was treated at 20 °C with thiol/thiolate (200 µL,
89 µmol). Reactions were quenched (200 µL, 1% TFA/ACN). The
solution and subsequent washings (H2O/CH3CN, 7 : 1) were analyzed
by HPLC.
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linker and thiol exchange are used to facilitate the release of
peptides as thioesters.
None of these methods combine the ability to deprotect the
peptide on resin followed by it being released as a thioester
into solution. The present nucleophilic cleavage of the HMBA
linker with thiolates, allows for this convenient combination
and simultaneously reduces the overall number of synthetic
steps required for the synthesis of thioesters.
To demonstrate the preparative synthesis of esters, amides
and thioesters by the present approach, 150 mg aliquots of Ac-
Trp-Ala-HMBA (2a) resin were cleaved using ethanol, propyl-
amine or 1-propanethiol, respectively. Excess nucleophile was
evaporated and purification was performed by reverse phase
flash column chromatography (for further details, see the
ESI†). The products were analyzed by HPLC, NMR, and MS.
The purified compounds were isolated in yields of 77%, 90%
and 40%, respectively. Reaction with 1-propanethiol induced
racemization and 24 hour treatment resulted in complete
racemization and a 50 : 50 distribution of the two isomers. As a
consequence, glycine was preferred as the C-terminal amino
acid when thiols were used as nucleophiles.
Conclusions
In summary, we have provided a method for the synthesis of a
variety of C-terminally modified peptides, prepared by nucleo-
philic cleavage of fully deprotected, resin bound peptides. In
the absence of hydroxide ions, the HMBA–esters presented
good reactivity in substitution reactions with a large variety of
nucleophiles. Generally alcoholates react fast and eﬃciently,
with high purity of the target peptide esters, and are less sensi-
tive to steric bulk than the corresponding amines. Care needs
to be taken to prevent hydrolysis, which in some cases is
diﬃcult. The amines are less reactive nucleophiles but at a
high concentration they still react to form the corresponding
amides when less hindered, sterically. The reactions of the
amines do not require any additional base or strictly anhy-
drous conditions. Thioesters of peptides, valuable for native
chemical ligation reactions were successfully formed by reac-
tion of the HMBA linked peptides with thiolates. Because of
racemization in these reactions the C-terminal amino acid
used should preferably be glycine. Thus utilizing the diﬀerent
reactivities oﬀered by the HMBA linker, the present methodo-
logy alleviates the urgent need for specialized linkers, dedi-
cated to the introduction of a particular functionality.
Experimental section
General
All purchased chemicals were used without further purifi-
cation. All solvents were HPLC-grade. Solid phase synthesis
was performed on a VA800 resin, bead size 200–400 (loading
0.200 mmol g−1) from Versa matrix. Flash chromatography
(FC) was carried out on Merck silica gel 60 (0.040–0.063 mm)
and analytical TLC was performed using Merck silica gel 60
F254 aluminum plates. Vacuum liquid chromatography (VLC)
was carried out on Merck silica gel 60 (0.015–0.040 mm) or on
IST Isolute Sorbent C18 gel 60 (0.040–0.070 mm). All HPLC
analyses were performed on an analytical Agilent 1100
HPLC-MS using a 100 mm XBridge C18 column. A linear gradi-
ent of acetonitrile in water with 0.1% TFA was used, running
from 0% to 90% acetonitrile, 1 mL min−1 over 10 min. The
detection was performed by measurement of the absorbance
of 254 nm UV-light. NMR spectra were recorded on a Bruker
ADVANCE III 500 MHz CRYO probe instrument. Chemical
shifts are reported in ppm relative to residual solvent signals
(CDCl3, 7.26 ppm; DMSO-d6, 2.50 ppm) for
1H NMR spectra
and relative to the central solvent resonance (CDCl3, 77.0 ppm;
DMSO-d6, 39.5 ppm) for
13C NMR spectra. The following
abbreviations are used to indicate the multiplicity in 1H and
13C NMR spectra: s, singlet; d, doublet; t, triplet; q, quartet;
dd, double doublet; ddd, double double doublet; dddd,
double double double doublet; dt, double triplet; m, multiplet.
13C spectra were acquired in broadband decoupled mode.
High resolution mass spectrometry (HRMS) was performed on
a Bruker micro-TOF using positive electrospray ionization.
Synthesis of test substrates
Esterification of the resin with Fmoc amino acids in dichloro-
methane (DCM) was carried out using the conditions reported
by Blankemeyer-Menge et al.28 All peptide couplings followed
the standard Fmoc based synthesis conditions with preactiva-
tion (3 min) of Fmoc-amino acid (3 equiv.), with 2-(1-H-benzo-
triazolyl-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate
(TBTU) (2.9 equiv.) and 4-ethylmorpholine (NEM) (4 equiv.) in
N,N-dimethylformamide (DMF). These conditions were also
used for N-terminal acetylation using acetic acid. Fmoc-clea-
vage was achieved with 20% piperidine in DMF and between
reactions the resin was washed with 10 resin volumes of DMF.
General procedure for cleavage using sodium hydroxide
Resin (5 mg, 1 µmol) was transferred to a filtration column
(2 mL). Aqueous sodium hydroxide (200 µL, 0.1 M) was added
to the resin and the mixture was allowed to react for 15 min.
The solution was neutralized using aqueous hydrochloric acid
(200 µL, 0.1 M) and the eluate was collected. Any remaining
product was extracted from the resin by washing with 7 : 3
H2O/CH3CN containing TFA (1%, 2 × 200 µL). The combined
solution was analysed by quantitative HPLC.
Method 1. General procedure for cleavage using alcohols or
thiols
Vacuum dried resin (5 mg, 1 µmol) was transferred to a 2 mL
SPE filtration column. The cleavage solution (200 µL,
0.089 mmol, 89 equiv.) of alcoholate or thiolate in the corres-
ponding solvent prepared by addition of potassium t-butoxide
(10 mg, 0.089 mmol per mL of the solvent) was added to the
resin. The full conversion varied according to the structure of
the peptide and nucleophile, from 15 min to hours. The reac-
tion mixture was then acidified using TFA (1% in acetonitrile,
Organic & Biomolecular Chemistry Paper
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200 µL) and the eluate was collected. The remaining product
was extracted from the resin by washing with H2O/CH3CN
(7 : 3) containing TFA (1%, 2 × 200 µL). The combined eluate
was analysed by quantitative HPLC.
Method 2. General procedure for cleavage using amines
Vacuum dried resin (5 mg, 1 µmol) was transferred to a 2 mL
SPE filtration column. Amine (200 µL, 2.00–3.30 mmol,
2000–3300 equiv.) was added to the resin and the mixture was
allowed to react for 2–6 hours depending on the substrate
resin. The solution was quenched using TFA (1% in aceto-
nitrile 200 µL) and the eluate was collected. Any remaining
product was extracted from the resin by washing with H2O/
CH3CN (7 : 3) containing TFA (1%, 2 × 200 µL). The combined
solution was analysed by quantitative HPLC.
NMR Data of crude compounds
Ac-Trp-Gly-OH (1b). The compound was prepared by a
general procedure for sodium hydroxide cleavage on resin 1a.
1H NMR (500 MHz, DMSO-d6) δ 12.54 (s, 1H), 10.82 (s, 1H),
8.34 (t, J = 5.8 Hz, 1H), 8.07 (d, J = 8.4 Hz, 1H), 7.60 (dd, J = 7.9,
1.0 Hz, 1H), 7.34–7.32 (m, 1H), 7.14 (d, J = 2.4 Hz, 1H), 7.06
(ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.97 (ddd, J = 8.0, 6.9, 1.1 Hz,
1H), 4.56 (ddd, J = 9.6, 8.4, 4.5 Hz, 1H), 3.77 (d, J = 5.9 Hz, 2H),
3.14 (ddd, J = 14.6, 4.6, 0.9 Hz, 1H), 2.96–2.85 (m, 1H), 1.77
(s, 3H). m/z [M + H+], calc.: 304.1292, found: 304.1299.
Ac-Trp-Ala-OH (2b). The compound was prepared by a
general procedure for sodium hydroxide cleavage on resin 2a.
1H NMR (500 MHz, DMSO-d6) δ 10.81 (s, 1H), 8.33 (d, J = 7.2
Hz, 1H), 8.00 (d, J = 8.3 Hz, 1H), 7.63 (d, J = 7.7 Hz, 1H),
7.50–7.41 (m, 2H), 7.06 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H), 6.98
(ddd, J = 8.0, 6.9, 1.0 Hz, 1H), 4.57 (ddd, J = 9.7, 8.3, 4.2 Hz,
1H), 4.24 (p, J = 7.3 Hz, 1H), 3.11 (dd, J = 14.7, 4.2 Hz, 1H),
2.88 (dd, J = 14.7, 9.6 Hz, 1H), 1.75 (s, 3H), 1.30 (d, J = 7.3 Hz,
3H). m/z [M + H+], calc.: 318.1448, found: 318.1457.
Ac-Trp-Ile-OH (3b). The compound was prepared by a
general procedure for sodium hydroxide cleavage on resin 3a.
1H NMR (500 MHz, DMSO-d6) δ 12.63 (s, 1H), 10.83 (s, 1H),
8.05 (dd, J = 8.3, 4.1 Hz, 2H), 7.61 (d, J = 7.8 Hz, 1H), 7.23 (ddt,
J = 7.5, 6.2, 3.3 Hz, 1H), 7.14 (d, J = 2.4 Hz, 1H), 7.06 (ddd, J =
8.2, 6.9, 1.2 Hz, 1H), 6.97 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 4.64
(ddd, J = 9.5, 8.2, 4.5 Hz, 1H), 4.21 (dd, J = 8.3, 6.0 Hz, 1H),
3.09 (dd, J = 14.8, 4.4 Hz, 1H), 2.90 (dd, J = 14.7, 9.6 Hz, 1H),
1.80 (ddt, J = 6.2, 4.7, 3.2 Hz, 1H), 1.76 (s, 3H), 1.44 (ddd, J =
13.6, 7.4, 4.4 Hz, 1H), 1.20 (ddd, J = 13.7, 9.1, 7.2 Hz, 1H),
0.91–0.82 (m, 6H). m/z [M + H+], calc.: 360.1918, found:
360.1925.
Ac-Trp-Gly-O-Me (4). The compound was prepared by
method 1, using MeOH and resin 1a. 1H NMR (500 MHz,
DMSO-d6) δ 10.81 (s, 1H), 8.45 (t, J = 5.9 Hz, 1H), 8.08 (d, J =
8.3 Hz, 1H), 7.60 (d, J = 7.9 Hz, 1H), 7.33 (d, J = 8.0 Hz, 1H),
7.14 (d, J = 2.4 Hz, 1H), 7.09–7.03 (m, 1H), 6.98 (ddd, J = 8.0,
6.9, 1.1 Hz, 1H), 4.56 (td, J = 8.9, 4.8 Hz, 1H), 3.85 (dd, J = 5.9,
2.4 Hz, 2H), 3.64 (s, 3H), 3.14 (dd, J = 14.7, 4.7 Hz, 1H), 2.89
(dd, J = 14.7, 9.4 Hz, 1H), 1.78 (s, 3H). m/z [M + H+], calc.:
318.1448, found: 318.1454.
Ac-Trp-Ala-O-Me (5). The compound was prepared by
method 1, using MeOH and resin 2a. 1H NMR (500 MHz,
DMSO-d6) δ 10.81 (s, 1H), 8.47 (d, J = 7.0 Hz, 1H), 8.02 (d, J =
8.3 Hz, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.36–7.28 (m, 1H), 7.14 (d,
J = 2.4 Hz, 1H), 7.06 (ddd, J = 8.1, 7.0, 1.2 Hz, 1H), 6.98 (ddd,
J = 7.8, 6.9, 1.0 Hz, 1H), 4.57 (td, J = 8.9, 4.7 Hz, 1H), 4.30 (p,
J = 7.2 Hz, 1H), 3.62 (s, 3H), 3.10 (dd, J = 14.7, 4.7 Hz, 1H), 2.88
(dd, J = 14.7, 9.3 Hz, 1H), 1.76 (s, 3H), 1.29 (d, J = 7.3 Hz, 3H).
m/z [M + H+], calc.: 332.1605, found: 332.1610.
Ac-Trp-Ile-O-Me (6). The compound was prepared by
method 1, using MeOH and resin 3a. 1H NMR (500 MHz,
DMSO-d6) δ 10.81 (s, 1H), 8.24 (d, J = 8.0 Hz, 1H), 8.02 (d, J =
8.2 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H),
7.12 (d, J = 2.4 Hz, 1H), 7.06 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H), 6.98
(td, J = 7.4, 6.9, 1.0 Hz, 1H), 4.65 (td, J = 8.7, 5.0 Hz, 1H), 4.23
(dd, J = 8.0, 6.5 Hz, 1H), 3.62 (s, 3H), 3.07 (dd, J = 14.7, 5.0 Hz,
1H), 2.89 (dd, J = 14.7, 9.0 Hz, 1H), 1.83–1.78 (m, 1H), 1.77 (s,
3H), 1.42 (dqd, J = 14.8, 7.4, 4.3 Hz, 1H), 1.18 (ddd, J = 13.8,
9.0, 7.3 Hz, 1H), 0.86–0.82 (m, 6H). m/z [M + H+], calc.:
374.2074, found: 374.2078.
Ac-Trp-Gly-O-Et (7). The compound was prepared by
method 1, using EtOH and resin 1a. 1H NMR (500 MHz,
DMSO-d6) δ 10.80 (s, 1H), 8.44 (t, J = 5.9 Hz, 1H), 8.07 (d, J =
8.3 Hz, 1H), 7.60 (d, J = 7.9 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H),
7.14 (d, J = 2.4 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.98 (t, J =
7.4 Hz, 1H), 4.56 (td, J = 9.0, 4.7 Hz, 1H), 4.10 (q, J = 7.1 Hz,
2H), 3.83 (dd, J = 6.0, 4.2 Hz, 2H), 3.14 (dd, J = 14.7, 4.6 Hz,
1H), 2.89 (dd, J = 14.7, 9.4 Hz, 1H), 1.78 (s, 3H), 1.20 (t, J =
7.1 Hz, 3H). m/z [M + H+], calc.: 332.1605, found: 332.1621.
Ac-Trp-Ile-O-Et (9). The compound was prepared by method
1, using EtOH and resin 3a. 1H NMR (500 MHz, DMSO-d6)
δ 10.80 (s, 1H), 8.22 (d, J = 8.0 Hz, 1H), 8.02 (d, J = 8.2 Hz, 1H),
7.61 (d, J = 7.8 Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.13 (d, J =
2.4 Hz, 1H), 7.06 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.98 (td, J = 7.4,
6.8, 1.0 Hz, 1H), 4.65 (td, J = 8.8, 4.8 Hz, 1H), 4.21 (dd, J = 8.0,
6.4 Hz, 1H), 4.09 (m, J = 10.9, 7.1 Hz, 2H), 3.08 (dd, J = 14.7,
4.8 Hz, 1H), 2.89 (dd, J = 14.7, 9.2 Hz, 1H), 1.79 (td, J = 4.0,
1.8 Hz, 1H), 1.77 (s, 3H), 1.43 (ddd, J = 13.6, 7.4, 4.4 Hz, 1H),
1.18 (t, J = 7.1 Hz, 3H), 0.85 (m, J = 7.2, 2.8 Hz, 6H). m/z
[M + H+], calc.: 388.2231, found: 388.2249.
Ac-Trp-Ile-O-iPr (12). The compound was prepared by
method 1, using isoPrOH and resin 3a. 1H NMR (500 MHz,
DMSO-d6) δ 10.81 (s, 1H), 8.20 (d, J = 7.8 Hz, 1H), 8.03 (d, J =
8.2 Hz, 1H), 7.61 (d, J = 7.9 Hz, 1H), 7.32 (d, J = 7.9 Hz, 1H),
7.13 (d, J = 2.4 Hz, 1H), 7.09–7.02 (m, 1H), 6.98 (t, J = 7.4 Hz,
1H), 4.92 (p, J = 6.3 Hz, 1H), 4.72–4.59 (m, 1H), 4.17 (dd, J =
7.9, 6.3 Hz, 1H), 3.08 (dd, J = 14.7, 4.5 Hz, 1H), 2.89 (dd, J =
14.7, 9.4 Hz, 1H), 1.79 (s, 1H), 1.76 (s, 3H), 1.48–1.37 (m, 1H),
1.22–1.16 (m, 6H), 0.90–0.83 (m, 6H). m/z [M + H+], calc.:
402.2387, found: 402.2400.
Ac-Trp-Ile-O-iBu (15). The compound was prepared by
method 1, using isoBuOH and resin 3a. 1H NMR (500 MHz,
DMSO-d6) δ 10.80 (s, 1H), 8.24 (d, J = 8.0 Hz, 1H), 8.04 (d, J =
8.3 Hz, 1H), 7.61 (d, J = 7.9 Hz, 1H), 7.32 (dd, J = 8.1, 1.0 Hz,
1H), 7.13 (d, J = 2.4 Hz, 1H), 7.06 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H),
6.98 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 4.66 (ddd, J = 9.6, 8.2, 4.6
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Hz, 1H), 4.26 (dd, J = 8.0, 6.3 Hz, 1H), 3.84 (dd, J = 6.4, 2.2 Hz,
2H), 3.07 (dd, J = 14.8, 4.6 Hz, 1H), 2.89 (dd, J = 14.7, 9.5 Hz,
1H), 1.93–1.83 (m, 1H), 176 (s, 3H), 1.47–1.37 (m, 1H),
1.24–1.17 (m, 1H), 0.93–0.82 (m, 13H). m/z [M + H+], calc.:
416.2544, found: 416.2562.
Ac-Trp-Ala-HMBA-NH2 (16). The compound was prepared by
standard solid phase synthesis on Rink amide linker functio-
nalized resin, and the compound was cleaved from the resin,
using a TFA cleavage mixture (TFA/phenol/H2O/TIPS,
88 : 5 : 5 : 2) and reduced on a freeze dryer. The compound was
purified by reverse phase flash column chromatography and
isolated in 50% yield, compared to loading after first amino
acid coupling and was used without further purification.
1H NMR (500 MHz, DMSO-d6) δ 10.78 (s, 1H), 8.56 (d, J =
6.9 Hz, 1H), 8.04 (d, J = 8.3 Hz, 1H), 7.97 (s, 1H), 7.90–7.84 (m,
2H), 7.59 (dd, J = 7.9, 1.0 Hz, 1H), 7.44 (d, J = 8.3 Hz, 2H), 7.37
(s, 1H), 7.32 (dt, J = 8.2, 0.9 Hz, 1H), 7.13 (d, J = 2.4 Hz, 1H),
7.06 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.97 (ddd, J = 8.0, 6.9,
1.1 Hz, 1H), 5.18 (s, 2H), 4.59 (ddd, J = 9.8, 8.3, 4.4 Hz, 1H),
4.38 (p, J = 7.2 Hz, 1H), 3.12–3.03 (m, 1H), 2.85 (dd, J = 14.8,
9.8 Hz, 1H), 1.76 (s, 3H), 1.34 (d, J = 7.4 Hz, 3H). 13C-NMR
DMSO-d6 δ: 172.3, 171.9, 169.0, 167.4, 139.2, 136.0, 133.8,
127.5, 127.2, 127.2, 123.5, 120.8, 118.4, 118.1, 111.2, 110.1,
65.3, 52.8, 47.7, 27.8, 22.5, 16.7. m/z [M + H+], calc.: 451.1976,
found: 451.1980.
Ac-Trp-Ala-O-iBu (14). The compound was prepared in solu-
tion by peptide coupling of N-Boc-L-tryptophan (341 mg,
1.12 mmol) and L-alanine-OiBu (326 mg, 2.24 mmol), using
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluoro-
phosphate (PyPOB) (1.0 equiv.) and N,N-diisopropylethylamine
(DIPEA) (2 equiv.) in CH2Cl2 at rt, for 2 h.
29 The Boc-protecting
group was removed with TFA (95% in H2O) and then N-termi-
nus was acetylated using acetic anhydride (229 mg,
2.24 mmol) and NEM (516 mg, 4.48 mmol) in DCM at rt, for
3 hours. The final compound was isolated by evaporation of
the reaction solution, followed by silica gel column purifi-
cation, yielding a white solid in 60% yield over 3 steps.
1H NMR (500 MHz, DMSO-d6) δ 10.79 (s, 1H), 8.50 (d, J =
7.0 Hz, 1H), 8.03 (d, J = 8.4 Hz, 1H), 7.64 (dd, J = 7.9, 1.0 Hz,
1H), 7.33 (dt, J = 8.1, 1.0 Hz, 1H), 7.15 (d, J = 2.4 Hz, 1H), 7.06
(ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.98 (ddd, J = 8.0, 7.0, 1.1 Hz,
1H), 4.59 (ddd, J = 9.9, 8.4, 4.3 Hz, 1H), 4.36–4.27 (m, 1H),
3.92–3.80 (m, 2H), 3.14–3.07 (m, 1H), 2.93–2.84 (m, 1H),
1.91–1.83 (m, 1H), 1.75 (s, 3H), 1.32 (d, J = 7.3 Hz, 3H), 0.89 (d,
J = 6.7 Hz, 6H). 13C NMR (126 MHz, DMSO-d6) δ 172.43,
171.79, 168.94, 135.99, 127.27, 123.53, 120.76, 118.43, 118.08,
111.20, 110.16, 70.12, 52.85, 47.68, 27.87, 27.29, 22.50, 18.75,
16.90, 16.90. m/z [M + H+], calc.: 374.2074, found: 374.2097.
Relative reactivity between HMBA and ethylester
Dry compound 16 (1 mg, 2.2 µmol) or 17 (1 mg, 2.7 µmol) was
dissolved in dry ethanol (100 µL). Dry ethanol (100 µL) contain-
ing potassium tert-butoxide (1 mg) was added. Samples (50 µL)
were collected and quenched using 2% TFA in CH3CN
(200 µL,) after 15, 30 and 60 s for compound 16 and 2, 5 and
10 min for compound 17. The reaction temperatures were at
all times fixed at 20 °C and conversion was assessed by quanti-
tative HPLC. The 4-carbamoyl peptide 16 was reduced by
75% within 30 seconds and verified using LC-MS, whereas the
iBu-ester 17 was still present in 15% after 10 min. The half-
times t1/2 of the reaction with ethanolate were 12 seconds for
16 and 2.25 min for 17 respectively.
Ac-Trp-Gly-NH-Pr (19). The compound was prepared by
method 2, using PrNH2 and resin 1a.
1H NMR (500 MHz,
DMSO-d6) δ 10.82 (s, 1H), 8.32 (t, J = 5.9 Hz, 1H), 8.16 (d, J =
7.2 Hz, 1H), 7.58 (d, J = 7.9 Hz, 1H), 7.54 (t, J = 5.8 Hz, 1H),
7.33 (d, J = 8.0 Hz, 1H), 7.18 (d, J = 2.3 Hz, 1H), 7.06 (t, J =
7.5 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 4.49–4.39 (m, 1H), 3.12
(dd, J = 14.6, 5.3 Hz, 1H), 3.00 (m, J = 6.4 Hz, 3H), 1.81 (s, 3H),
1.39 (q, J = 7.2 Hz, 2H), 0.83 (t, J = 7.4 Hz, 3H). m/z [M + H+],
calc.: 345.1921, found: 345.1921.
Ac-Trp-Gly-NH-iPr (22). The compound was prepared by
method 2, using isoPrNH2 and resin 1a.
1H NMR (500 MHz,
DMSO-d6) δ 10.82 (s, 1H), 8.31 (t, J = 5.9 Hz, 1H), 8.17 (d, J =
7.1 Hz, 1H), 7.58 (d, J = 7.8 Hz, 1H), 7.47 (d, J = 7.8 Hz, 1H),
7.33 (d, J = 8.0 Hz, 1H), 7.18 (d, J = 2.4 Hz, 1H), 7.06 (ddd, J =
8.1, 6.9, 1.2 Hz, 1H), 6.98 (ddd, J = 7.9, 6.9, 1.0 Hz, 1H), 4.43
(ddd, J = 9.1, 7.1, 5.2 Hz, 1H), 3.89–3.80 (m, 1H), 3.69 (dd, J =
16.5, 6.2 Hz, 1H), 3.53 (dd, J = 16.5, 5.5 Hz, 1H), 3.11 (dd, J =
14.7, 5.2 Hz, 1H), 2.92 (dd, J = 14.8, 9.1 Hz, 1H), 1.81 (s, 3H),
1.05 (dd, J = 10.8, 6.6 Hz, 6H). m/z [M + H+], calc.: 345.1921,
found: 345.1921.
Ac-Trp-Gly-NH-iBu (25). The compound was prepared by
method 2, using isoBuNH2 and resin 1a.
1H NMR (500 MHz,
DMSO-d6) δ 10.82 (s, 1H), 8.33 (t, J = 5.9 Hz, 1H), 8.17 (d, J =
7.2 Hz, 1H), 7.59–7.57 (m, 1H), 7.55 (t, J = 5.8 Hz, 1H), 7.33
(dd, J = 8.1, 1.0 Hz, 1H), 7.17 (d, J = 2.4 Hz, 1H), 7.06 (ddd, J =
8.2, 7.0, 1.2 Hz, 1H), 6.98 (ddd, J = 8.0, 6.9, 1.1 Hz, 1H), 4.44
(ddd, J = 9.0, 7.2, 5.2 Hz, 1H), 3.20–3.05 (m, 1H), 2.97–2.92 (m,
1H), 2.91–2.83 (m, 4H), 1.80 (s, 3H), 1.67 (hept, J = 6.7 Hz, 1H),
0.82 (dd, J = 6.7, 1.5 Hz, 6H). m/z [M + H+], calc.: 359.2078,
found: 359.2077.
Ac-Trp-Ala-NH-iBu (26). The compound was prepared by
method 2, using isoBuNH2 and resin 2a.
1H NMR (500 MHz,
DMSO-d6) δ 10.82 (s, 1H), 8.05 (dd, J = 14.0, 7.7 Hz, 2H),
7.61–7.54 (m, 2H), 7.35–7.30 (m, 1H), 7.16 (d, J = 2.4 Hz, 1H),
7.06 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.97 (ddd, J = 7.9, 6.9, 1.0
Hz, 1H), 4.53 (ddd, J = 8.9, 7.8, 4.9 Hz, 1H), 4.23 (p, J = 7.1 Hz,
1H), 3.11 (dd, J = 14.7, 4.9 Hz, 1H), 2.91–2.82 (m, 4H), 1.78 (s,
3H), 1.64 (hept, J = 6.7 Hz, 1H), 1.20 (d, J = 7.1 Hz, 3H), 0.81
(dd, J = 6.7, 1.6 Hz, 6H). m/z [M + H+], calc.: 373.2234, found:
373.2234.
Ac-Trp-Gly-S-Pr (34). The compound was prepared by
method 1, using PrSH and resin 1a. 1H NMR (500 MHz,
DMSO-d6) δ 10.80 (s, 1H), 8.72 (t, J = 6.0 Hz, 1H), 8.12 (d, J =
8.2 Hz, 1H), 7.62 (dd, J = 7.9, 1.0 Hz, 1H), 7.35–7.31 (m, 1H),
7.15 (d, J = 2.4 Hz, 1H), 7.07 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.99
(ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 4.58 (ddd, J = 9.8, 8.2, 4.5 Hz,
1H), 4.12–3.88 (m, 2H), 3.20 (ddd, J = 14.7, 4.6, 0.9 Hz, 1H),
2.91 (dd, J = 14.6, 9.9 Hz, 1H), 2.81 (t, J = 7.1 Hz, 2H), 1.78
(s, 3H), 1.52 (h, J = 7.3 Hz, 2H), 0.91 (t, J = 7.3 Hz, 3H). m/z
[M + H+], calc.: 362.4675, found: 362.4663.
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Ac-Trp-Ala-O-Et (8). The compound was prepared by trans-
ferring vacuum dried resin (150 mg, 30 µmol) to a 5 mL SPE
filtration column. The cleavage solution (1000 µL, 0.44 mmol,
15 equiv.) of ethanolate in ethanol, prepared by addition of
potassium t-butoxide (50 mg, 0.44 mmol per mL of ethanol),
was added to the resin. After 30 min, the reaction mixture was
acidified using TFA (1% in acetonitrile, 1000 µL) and the
eluate was collected. The remaining product was extracted
from the resin by washing with H2O/CH3CN (7 : 3) containing
TFA (1%, 2 × 1000 µL). The combined eluate was analyzed by
quantitative HPLC, the volume was reduced and the com-
pound purified by reverse phase, flash chromatography.
1H NMR (500 MHz, DMSO-d6) δ 10.80 (s, 1H), 8.47 (d, J =
7.0 Hz, 1H), 8.02 (d, J = 8.3 Hz, 1H), 7.64 (dd, J = 7.8, 1.0 Hz,
1H), 7.33 (dt, J = 8.1, 0.9 Hz, 1H), 7.15 (d, J = 2.4 Hz, 1H), 7.06
(ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.98 (ddd, J = 8.0, 7.0, 1.1 Hz,
1H), 4.58 (ddd, J = 9.5, 8.3, 4.5 Hz, 1H), 4.27 (p, J = 7.2 Hz, 1H),
4.09 (qd, J = 7.1, 3.1 Hz, 2H), 3.11 (ddd, J = 14.7, 4.5, 0.9 Hz,
1H), 2.96–2.80 (m, 1H), 1.76 (s, 3H), 1.30 (d, J = 7.3 Hz, 3H),
1.18 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, DMSO) δ 172.4,
171.8, 169.0, 136.0, 127.3, 123.5, 120.8, 118.4, 118.1, 111.2,
110.1, 60.4, 52.9, 47.7, 27.8, 22.5, 16.8, 14.0. m/z [M + H+],
calc.: 346.1761, found: 346.1783.
Ac-Trp-Ala-NH-Pr (20). The compound was prepared by
transferring vacuum dried resin (150 mg, 30 µmol) to a 5 mL
SPE filtration column. Propylamine (1000 µL, 12.15 mmol, 450
equiv.) was added. After 120 min, the reaction was quenched
by adding a small amount of TFA (1% in acetonitrile, 1000 µL)
and the eluate was collected. The remaining product was
extracted from the resin by washing with H2O/CH3CN (7 : 3)
containing TFA (1%, 2 × 1000 µL). The combined eluate was
analyzed by quantitative HPLC, the volume was reduced and
the compound purified by reverse phase, flash chromato-
graphy. 1H NMR (500 MHz, DMSO-d6) δ 10.82 (s, 1H), 8.05
(t, J = 7.2 Hz, 2H), 7.60 (dd, J = 7.7, 1.0 Hz, 1H), 7.53 (t, J = 5.8 Hz,
1H), 7.32 (dt, J = 8.1, 0.9 Hz, 1H), 7.16 (d, J = 2.4 Hz, 1H), 7.06
(ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 6.98 (ddd, J = 8.0, 7.0, 1.1 Hz,
1H), 4.54 (ddd, J = 8.8, 7.8, 5.1 Hz, 1H), 4.21 (p, J = 7.1 Hz, 1H),
3.17–3.08 (m, 1H), 2.96 (qd, J = 7.0, 2.2 Hz, 2H), 2.93–2.88 (m,
1H), 1.79 (s, 3H), 1.36 (h, J = 7.3 Hz, 2H), 1.19 (d, J = 7.1 Hz,
3H), 0.82 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, DMSO)
δ 171.7, 171.3, 169.3, 158.4, 158.1, 136.0, 127.3, 123.5, 120.8,
118.4, 118.1, 111.2, 110.1, 53.4, 48.3, 27.6, 22.5, 22.2, 18.2,
11.2. m/z [M + H+], calc.: 359.2078, found: 359.2078.
Ac-Trp-Ala-S-Pr (35). The compound was prepared by trans-
ferring vacuum dried resin (150 mg, 30 µmol) to a 5 mL SPE
filtration column. The cleavage solution (1000 µL, 0.44 mmol,
15 equiv.) of propane-1-thiolate in 1-propanethiol, prepared by
addition of potassium t-butoxide (50 mg, 0.44 mmol per mL
1-propanethiol), was added to the resin. The reaction time was
24 h, after which the reaction mixture was acidified using TFA
(1% in acetonitrile, 1000 µL) and the eluate was collected. The
remaining product was extracted from the resin by washing
with H2O/CH3CN (7 : 3) containing TFA (1%, 2 × 1000 µL). The
combined eluate was analyzed by quantitative HPLC, the
volume was reduced and the compound purified by reverse
phase, flash chromatography. 1H NMR (500 MHz, DMSO-d6) δ
10.72 (s, 1H), 8.71 (d, J = 7.2 Hz, 0.5H), 8.52 (d, J = 7.4 Hz,
0.5H), 8.00 (dd, J = 8.3, 2.8 Hz, 1H), 7.61 (d, J = 7.8 Hz, 0.5H),
7.51 (d, J = 7.8 Hz, 0.5H), 7.30–7.22 (m, 1H), 7.08 (dd, J = 14.5,
2.4 Hz, 1H), 6.99 (m, J = 8.1, 6.6, 5.3, 1.2 Hz, 1H), 6.95–6.86 (m,
1H), 4.62–4.51 (m, 1H), 4.34 (p, J = 7.2 Hz, 0.5H), 4.23 (p,
J = 7.2 Hz, 0.5H), 3.16 (dd, J = 14.7, 4.1 Hz, 0.5H), 3.01 (dd, J =
14.5, 5.6 Hz, 0.5H), 2.83 (m, J = 14.7, 9.4 Hz, 1H), 2.69 (dd, J =
7.8, 6.4 Hz, 2H), 1.72 (s, 1.5H), 1.67 (s, 1.5H), 1.43 (m, J = 7.3,
2.2 Hz, 2H), 1.22 (d, J = 7.3 Hz, 1.5H), 1.08 (d, J = 7.3 Hz, 1.5H),
0.82 (td, J = 7.3, 3.1 Hz, 3H). 13C NMR (126 MHz, DMSO) δ
202.0, 171.8, 168.8, 136.0, 127.3, 123.7, 120.8, 118.4, 111.2,
110.1, 99.5, 53.0, 29.6, 28.0, 27.4, 22.5, 22.4, 17.3, 13.1. m/z
[M + H+], calc.: 376.1689, found: 376.1660 m/z [M + H+], calc.:
376.1689, found: 376.1660.
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